Will AI solve medicine?

Artificial intelligence is transforming how we discover and develop new medicines. But how far can it really take us? In this episode, Jacob and Saloni trace the path of drug development from discovery to testing, manufacturing, and delivery. They explore where AI could speed things up, and where it still hits the limits of biology, data, and economics. They ask what it would take, beyond algorithms, to actually cure and eradicate diseases.

Hard Drugs is a new podcast from Works in Progress and Open Philanthropy about medical innovation presented by Saloni Dattani and Jacob Trefethen.

You can watch or listen on YouTube, Spotify, or Apple Podcasts.

Saloni’s substack newsletter: https://www.scientificdiscovery.dev/

Jacob’s blog: https://blog.jacobtrefethen.com/ 

Chapters:
0:00:00 Intro
0:09:56 Drug discovery
1:02:20 Animal models
1:49:09 Drug efficacy
2:32:56 Drug safety
2:58:29 Manufacturing and healthcare
3:43:23 R&D funding
4:00:56 Trust and ambition
4:16:01 Summary

Blogposts:
Articles:
Books:
  • Sally Smith Hughes (2011) Genentech: The beginnings of biotech
Theses:
  • Alvaro Schwalb (2025). Estimating the burden of Mycobacterium tuberculosis infection and the impact of population-wide screening for tuberculosis.
Acknowledgements:
  • Aria Babu, editor at Works in Progress
  • Graham Bessellieu, video editor
  • Abhishaike Mahajan, cover art
  • Atalanta Arden-Miller, art direction
  • David Hackett, composer
Works in Progress & Open Philanthropy

Subscribe to the Works in Progress print magazine: https://worksinprogress.co/print/
Will AI solve medicine?